Cervix News and Research

RSS

WVU gynecologic oncologist investigates novel treatment for cervical and vaginal cancers

Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years--silently growing, spreading and invading other organs--and by the time they're detected, they may be so advanced that the patient's prognosis is poor and her treatment options few.

15 Feb 2019

Female reproductive tract blocks weak sperm from reaching egg

A new study has found that slow-swimming sperm are disadvantaged by narrow areas of the female reproductive tract, preventing them from reaching an egg.

14 Feb 2019

Misconceptions surrounding HPV are causing women to miss smear tests

A survey has found that a “concerning” level of misunderstanding and stigma surrounding HPV could be putting women off going for cervical smear tests.

13 Feb 2019

Social stigmas surrounding HPV could put women off going for cervical screening

The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, including raising fears about their partners' fidelity and putting them off going for cervical screening, according to research presented at Cancer Research UK's Early Diagnosis Conference in Birmingham today.

12 Feb 2019

High-risk sexually transmitted HPV may increase risk of cardiovascular disease

Infection with high-risk strains of the human papillomavirus, which have been linked to cancer, might increase the risk of heart and blood vessel or cardiovascular disease, especially among women with obesity or other cardiovascular risk factors, according to new research in Circulation Research, an American Heart Association journal.

7 Feb 2019

Study develops simple, new treatment to fight Candida Albicans fungus

A study led by the UPV/EHU has developed an innovative, simple treatment based uterine stem cells to combat the Candida Albicans fungus, responsible for vaginal candidiasis disease.

5 Feb 2019

Thousands of girls in the UK have not been vaccinated against HPV

The PHE campaign to vaccinate all girls between the ages of 12 and 18 years against HPV was only achieved in two-thirds of the population between 2017-2018.

25 Jan 2019

FDA authorizes marketing of new test to aid in the diagnosis of M. gen. infections

The U.S. Food and Drug Administration today permitted marketing of a new test to aid in the diagnosis of a sexually-transmitted infection called Mycoplasma genitalium (M. gen.).

23 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Young women skipping the Pap smear test due to embarrassment

The Pap smear test is one of the easiest ways to screen young women for cervical cancer. Cervical cancer kills thousands of women and if detected early can be treated successfully. A new problem has arisen however with the smear test. Many young women are embarrassed about getting a Pap smear test routinely to screen against cervical cancer.

22 Jan 2019

Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives

University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices

21 Jan 2019

Cervical cancer screening rates are unacceptably low, finds Mayo Clinic study

The percentage of women who are screened for cervical cancer may be far lower than national data suggests, according to a Mayo Clinic study recently published in the Journal of Women's Health. Less than two-thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016.

7 Jan 2019

New 'epigenetics-based' cervical cancer test outperforms Pap smear and HPV tests

A new test for cervical cancer was found to detect all of the cancers in a randomized clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus test at a reduced cost, according to a study led by Queen Mary University of London.

17 Dec 2018

HPV type 16 or 18 associated with cervical cancer risk in young women

The human papilloma virus can cause cervical cancer. According to new guidelines in Sweden, women over thirty therefore undergo initial screening for the virus rather than a smear test.

10 Dec 2018

Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities

Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus types but do not show any signs of cellular abnormalities.

10 Dec 2018

Mailing at-home HPV tests may be viable approach for screening hard-to-reach women

Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the cervix.

28 Nov 2018

New report highlights key focus areas to help cancer screening realize its full potential

Cancer screening has contributed substantially to reduced incidence, morbidity, and mortality, but issues like access and quality care and have kept screening from fulfilling its full potential, according to a new report.

19 Nov 2018

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

An antibody that binds simultaneously to two distinct regions of the HER2 receptor to block the growth of cancer cells has shown promising signs of anti-tumor activity in a number of cancers including those of the gullet (esophagus), stomach and bowel.

14 Nov 2018

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Two recent studies find advances in radiation therapy are helping to prolong or improve the lives of people with anal cancer, including those whose cancer has advanced to stage IV.

8 Nov 2018

Study reveals how cancer-causing HPVs evolved

Cancer-causing human papillomaviruses diverged from their most recent common ancestors approximately half a million years ago, roughly coinciding with the timing of the split between archaic Neanderthals and modern Homo sapiens, according to a study published November 1 in the open-access journal PLOS Pathogens by Zigui Chen of the Chinese University of Hong Kong, Robert Burk of the Albert Einstein College of Medicine, and colleagues.

2 Nov 2018